Giannis Mountzios, PhD
Enriched profileDirector, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as "Director: Mountzios Ioannis") · Henry Dunant Hospital Center
Giannis Mountzios is Director, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as "Director: Mountzios Ioannis") at Henry Dunant Hospital Center. OpenAlex indexes 261 publications with 7,220 citations (h-index 41); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 9 Nov 2026
Overview
Updated 10 Nov 2026
Giannis Mountzios is Director, 4th Internal Medicine – Oncology Clinic, Henry Dunant Hospital (listed as "Director: Mountzios Ioannis") at Henry Dunant Hospital Center, Athens. The public record shows 261 publications with 7,220 citations (h-index 41), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 1 registered clinical trials.
- Most recent indexed publication: 2026 · Cancer research communications
- Top research focus: Lung Cancer Treatments and Mutations
- 1 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 10 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 26 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 107.
Clinical & industry
trials, payments and federal fundingNot shown. No U.S. clinical registration on file.
Federally funded research awards.
This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →
Contact
No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →
Clinical trials
Updated 9 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
Industry payments
Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 9 Nov 2026
41 congress contributions (2007–2026) across AACR, ASCO, ESMO, IASLC per OpenAlex. The most recent:
- A phase 3 study of sacituzumab govitecan in patients with previously treated extensive-stage small cell lung cancer.
ASCO Annual Meeting
ASCO2026Co-author - Association patterns among patient-reported adverse events in advanced NSCLC: A post-hoc analysis of the CLIMEDIN randomized controlled trial.
ASCO Annual Meeting
ASCO2026Co-author - Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 9 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.
Cancer research communications
Clinical Trial2026 - SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non-Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Study.
JCO clinical cancer informatics
Clinical Trial2026
Online presence
Updated 9 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
loop.frontiersin.org/people/634644
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →loop.frontiersin.org ↗
Mentions by others
where others cite or feature them- Other
dunant.gr/en/news/press-releases/press-releases-2025/anosotherapia-karkinou-pnevmona
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dunant.gr ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 9 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
- Member
Board of Directors, Hellenic Society for Medical Oncology (HESMO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Chair
Young Medical Oncologists Committee, Hellenic Society for Medical Oncology (HESMO) (former; years not stated)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
Awards & honors
honors on the public record- Fellowship
American Society of Clinical Oncology (ASCO) (year and award name not found)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Fellowship
European Society for Medical Oncology (ESMO) (year and award name not found)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Fellowship
Hellenic Society for Medical Oncology (HESMO) (year not found)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
Secondary affiliations
appointments beyond the home institution- Consultant Medical Oncologist
Department of Medical Oncology, Air Force General Hospital, Athens (older ESMO profile listing; conflicts with current Henry Dunant role)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗ - Scientific Co-ordinator
Lung Cancer Working Group, Hellenic Co-operative Oncology Group (HeCOG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Ignacio Wistuba, MD
Moffitt Cancer Center
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)